0001144204-19-009071.txt : 20190220 0001144204-19-009071.hdr.sgml : 20190220 20190220141852 ACCESSION NUMBER: 0001144204-19-009071 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20190220 DATE AS OF CHANGE: 20190220 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: P&F INDUSTRIES INC CENTRAL INDEX KEY: 0000075340 STANDARD INDUSTRIAL CLASSIFICATION: METALWORKING MACHINERY & EQUIPMENT [3540] IRS NUMBER: 221657413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-39826 FILM NUMBER: 19617887 BUSINESS ADDRESS: STREET 1: 445 BROADHOLLOW ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: (631)694-9800 MAIL ADDRESS: STREET 1: 445 BROADHOLLOW ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: PLASTICS & FIBERS INC DATE OF NAME CHANGE: 19671225 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HOROWITZ RICHARD A CENTRAL INDEX KEY: 0001114907 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 20596 LINKS CIRCLE CITY: BOCA RATON STATE: FL ZIP: 33434 SC 13D/A 1 tv514166_sc13da.htm SC 13D/A

 

Page 1 of 5

 

 

 UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No. 5)

 

P&F INDUSTRIES, INC.

(Name of Issuer)

 

Class A Common Stock

(Title of Class of Securities)

 

692830508

(CUSIP Number)

 

Gary T. Moomjian, Esq.

Moomjian, Waite & Coleman, LLP

100 Jericho Quadrangle, Suite 208

Jericho, New York 11753

(516) 937-5900

 

(Name, Address and Telephone Number of Person

Authorized to Receive Notice and Communications)

 

February 14, 2019

(Date of Event which requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f), or 13d-1(g), check the following box ¨.

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

Page 2 of 5

 

SCHEDULE 13D/A

 

CUSIP NO. 692830508

 

1.NAMES OF REPORTING PERSONS

 

Richard Horowitz

 

 

2.CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)¨

 

(b)¨

 

3.SEC USE ONLY

 

4.SOURCE OF FUNDS

Not applicable

 

5.CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨

_____________________________________________________________________________________________

6.CITIZENSHIP OR PLACE OF ORGANIZATION

United States of America

 

Number of 7. Sole Voting Power 1,346,306 shares of Class A Common Stock (1) (2)
Shares      
Beneficially 8. Shared Voting Power 0
Owned      
Each 9. Sole Dispositive Power 1,346,306 shares of Class A Common Stock (1) (2)
Reporting      
Person with: 10. Shared Dispositive Power 0
       

  

11.AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,346,306 shares of Class A Common Stock (1) 

 

12.CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨

 

13.PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

42.2% of outstanding Class A Common Stock

 

14.TYPE OF REPORTING PERSON

IN

 

 

(1)Includes 10,000 shares of Class A Common Stock underlying stock options exercisable within 60 days of the filing of this Amendment No. 5.

 

(2)See Item 6 in respect to Mr. Horowitz’s agreement relating to voting and disposition of shares.

 

 

Page 3 of 5

 

SCHEDULE 13D/A

  

Introductory Note:

 

This Amendment No. 5 (“Amendment No. 5”) amends a Statement on Schedule 13D dated May 18, 2000 by Richard Horowitz (the “Reporting Person” or “Mr. Horowitz”) and Linda Horowitz, as amended by Amendment No. 1 filed jointly by the Reporting Person, the Estate of Linda Horowitz (the “Estate”) and The Article FOURTH Trust u/w/o Linda Horowitz (the “Trust”) on May 23, 2007, Amendment No. 2 filed jointly by the Reporting Person, the Estate and the Trust on April 28, 2008, Amendment No. 3 filed jointly the Reporting Person and the Trust on July 5, 2014 and Amendment No. 4 filed by the Reporting Person on October 22, 2014 (such Statement on Schedule 13D as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3 and Amendment No. 4, the “Schedule 13D”).

 

This Amendment No. 5 is being filed to disclose an agreement between the Reporting Person and the Board of Directors (the “Board”) of P&F Industries, Inc. (the “Issuer” or the Company”) relating to the Fidelity Transaction (as defined below). Amendment No. 5 reflects (i) the repurchase by the Issuer of 29,971 shares of the Issuer’s Class A Common Stock (the “Common Stock”) between November 6, 2018 and February 15, 2019 through a publicly announced stock repurchase plan, (ii) the repurchase of 85,791 shares of Common Stock by the Issuer in a privately negotiated transaction effective November 19, 2018, (iii) an exercise of options to purchase 15,678 shares of Common Stock by an option holder and (iv) a repurchase by the Issuer of 389,909 shares from certain funds and accounts advised or sub-advised by Fidelity Management & Research Company or its affiliates in a privately negotiated transaction, effective February 15, 2019 (the “Fidelity Transaction”),

  

Item 4. Purposes of Transaction

 

The information contained in Item 4 of Schedule 13D is hereby amended and supplemented by incorporating the information set forth in Item 6 of this Amendment No. 5.

  

Item 5. Interest in Securities of the Issuer

 

The information contained in Item 5 of Schedule 13D is hereby amended by replacing it in its entirety with the following:

 

(a)Mr. Horowitz beneficially owns 1,346,306 shares of Common Stock, which includes 10,000 shares underlying stock options exercisable within 60 days of the filing of this Amendment No. 5. The shares of Common Stock beneficially owned by Mr. Horowitz represents approximately 42.2% of the Issuer’s outstanding shares of Common Stock as of February 15, 2019.

 

(b)Mr. Horowitz has sole voting power and sole dispositive power over the shares of Common Stock beneficially owned by him; however, reference is made to Item 6 in respect to Mr. Horowitz’s agreement relating to voting and disposition of shares.

 

(c)Not applicable.

 

(d)Not applicable.

 

(e)Not applicable.

 

 

Page 4 of 5

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

 

The information contained in Item 6 of Schedule 13D is hereby amended and supplemented by the following paragraph:

 

In contemplation and in view of the Fidelity Transaction, as a result of which the percentage ownership of Common Stock held by Mr. Horowitz has increased, Mr. Horowitz entered into an agreement, dated February 14, 2019 (the “Letter Agreement”) with the Board, pursuant to which Mr. Horowitz agreed that with respect to any vote of the Issuer’s shareholders, to the extent the percentage of Common Stock held by him and Grace Horowitz (his mother) exceeds a threshold amount, as determined pursuant to the Letter Agreement, such excess shares shall either not be voted or shall be voted proportionately with the vote of all holders of Common Stock other than shares of Common Stock held by Mr. Horowitz, Grace Horowitz or any other shareholder that is a Schedule 13D filer with respect to the Issuer, or as otherwise determined by a resolution of the majority of the independent directors of the Issuer. Additionally, pursuant to the Letter Agreement, Mr. Horowitz agreed to several other covenants, including the following:

 

1.He has no intent to acquire absolute majority control of the Issuer, and in any event will not offer (whether privately or publicly) to acquire the Issuer without the prior approval of the independent directors of the Issuer;

 

2.If an offer to acquire the Issuer or more than 20% of the equity of the Issuer is received from a third party, Mr. Horowitz will only sell his shares (or vote such shares) in a transaction approved by the independent directors of the Issuer and whereby all shareholders other than Mr. Horowitz receive no less favorable consideration (in timing, form and amount) than he receives for his shares (provided this clause shall not be deemed to restrict payment to Mr. Horowitz of any compensation related items);

 

3.Without the approval of a majority of the independent directors, Mr. Horowitz will not transfer shares of Common Stock other than (i) pursuant to Rule 144, (ii) to a person, who after giving effect to such transfer, has beneficial ownership of 4.9% or less of the Common Stock, or (iii) in a disposition to a relative or relatives or trust for the benefit of a relative or relatives where each transferee agrees to be bound by the terms hereof; and

 

4.Mr. Horowitz will not take any action to remove an independent director from the Board without the prior approval of either (i) a majority of the other independent directors, or (ii) a majority of shares of Common Stock (other than shares held by Mr. Horowitz, Grace Horowitz or any of such directors).

 

The provisions of the Letter Agreement terminate 90 days after the date the Common Stock held by Mr. Horowitz and Grace Horowitz are less than 35% of the then outstanding shares. In the Letter Agreement, Mr. Horowitz disclaims beneficial ownership of the shares of Common Stock held by Grace Horowitz.

 

The foregoing description of the terms of the Letter Agreement is qualified in its entirety by reference to the full text of such agreement, which is filed as Exhibit 1 hereto and incorporated herein by reference.

  

Item 7. Material to Be Filed as Exhibits

 

1.The Letter Agreement.

  

 

Page 5 of 5

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

February 19, 2019

 

  /s/ Richard Horowitz  
  Richard Horowitz  

 

 

 

EX-99.1 2 tv514166_ex1.htm EXHIBIT 1

 

Exhibit 1

 

February 14, 2019

 

The Board of Directors of P&F Industries, Inc.

445 Broadhollow Road, Suite 100

Melville NY, 11747

 

Attention: Mitchell A. Solomon, Lead Independent Director

To the Board of Directors:

 

I, Richard A. Horowitz, currently own 1,336,306 shares of the Class A Common Stock (“Common Stock”) of P&F Industries, Inc. (the “Company”) and hold options to acquire 30,000 shares of Common Stock.  My mother, Grace Horowitz, owns 217,471 shares of Common Stock.  Based on the Company’s total outstanding shares (3,581,692) as of January 28, 2019, my mother and I currently have an aggregate beneficial ownership of 43.9%, assuming exercise of all of my options. My holdings were subject to the earlier letter agreement of August 9, 2017, which is superseded by the execution and delivery of this letter agreement.

 

In connection with the deliberations of the Board of Directors of the Company with respect to approval of a repurchase of Common Stock from a fund managed by Fidelity Investment ("Fidelity"), I hereby agree and acknowledge that if I acquire the right to vote shares of Common Stock which, together with the shares held by my mother, causes the percentage of shares held by either me and my mother to exceed 42.5% of the shares eligible to vote on a matter ("excess shares"), I will either not vote such excess shares or I will cause them to be voted proportionately in accordance with the vote of all holders of Common Stock (other than shares held by me, my mother or any other 13(d) filer), or as otherwise determined by resolution of a majority of the independent directors of the Company.

 

In response to the issues identified to me by the independent directors of the Company with respect to the impact of the repurchase on my ownership level and my potential influence on matters that could affect the other shareholders of the Company, I hereby agree:

 

1.I have no intent to acquire absolute majority control of the Company, and in any event will not offer (whether privately or publicly) to acquire the Company without the prior approval of the independent directors of the Company.

 

2.If an offer to acquire the Company or more than 20% of the equity of the Company is received from a third party, I will only sell my shares (or vote such shares) in a transaction approved by the independent directors of the Company and whereby all shareholders other than me receive no less favorable consideration (in timing, form and amount) than I receive for my shares (provided this clause shall not be deemed to restrict payment to me of any compensation related items).

 

3.Without the approval of a majority of the independent directors, I will not transfer shares of Common Stock other than (i) pursuant to Rule 144, (ii) to a person, who after giving effect to such transfer, has beneficial ownership of 4.9% or less of the Company's Common Stock, or (iii) in a disposition to a relative or relatives or trust for the benefit of a relative or relatives where each transferee agrees to be bound by the terms hereof.

 

 

 

 

4.I will not take any action to remove an independent director from the board without the prior approval of either (i) a majority of the other independent directors, or (ii) a majority of shares of Common Stock (other than shares held by me, my mother or any of such directors).

 

5.If I violate or announce or demonstrate a plan to violate any of the foregoing covenants, I consent to the independent directors taking action on behalf of the Company to enforce the foregoing. I consent to the jurisdiction of the courts of Delaware. This agreement shall bind my successors and assigns.

 

6.The provisions of this letter shall become effective upon completion of the Fidelity transaction. This letter shall terminate (i) 45 days after the date hereof if the Fidelity transaction has not been consummated or (ii) 90 days after the date the shares held by me and my mother are less than 35% of the then outstanding shares.

 

Please note that I continue to disclaim beneficial ownership of my mother’s shares.

 

Very truly yours,

 

 

/s/ Richard A. Horowitz

Richard A. Horowitz

 

ACCEPTED:

 

 

/s/ Mitchell A. Solomon
Mitchell A. Solomon, on
behalf of the Board of Directors

 

2